The SWI/SNF complex member SMARCB1 supports lineage fidelity in kidney cancer
暂无分享,去创建一个
G. Ciriello | S. Vanharanta | A. Warren | Paulo Rodrigues | Saroor A. A. Patel | Debora Sesia | Veronica Caraffini | Anna E. Dyas | Jianfeng Ge | L. Wesolowski | Shoko Hirosue | Leticia Castillon | Anna Dyas | Sakari Vanharanta | Debora Sesia
[1] S. Lowe,et al. A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear Cell Renal Cell Carcinoma. , 2022, Cancer discovery.
[2] S. Chanock,et al. The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer , 2022, Nature.
[3] D. Langley,et al. PROTAC targeted protein degraders: the past is prologue , 2022, Nature Reviews Drug Discovery.
[4] T. Muir,et al. Chromatin landscape signals differentially dictate the activities of mSWI/SNF family complexes , 2021, Science.
[5] David R. Jones,et al. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients , 2021, Cell.
[6] E. Jonasch,et al. Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis , 2021, Nature Medicine.
[7] Steven L. Chang,et al. Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma , 2021, Nature Communications.
[8] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[9] Joshua M. Dempster,et al. Integrated cross-study datasets of genetic dependencies in cancer , 2020, Nature Communications.
[10] C. Mason,et al. Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation , 2020, Cancer cell.
[11] D. Pe’er,et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance , 2020, Nature Reviews Clinical Oncology.
[12] M. Rubin,et al. Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity , 2020, Nature Communications.
[13] S. Påhlman,et al. ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma. , 2020, Experimental cell research.
[14] C. Leslie,et al. ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer , 2020, Nature Genetics.
[15] C. Caldas,et al. ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response , 2019, Nature Genetics.
[16] R. Figlin,et al. HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma , 2019, Clinical Cancer Research.
[17] C. Caldas,et al. ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response , 2019, Nature Genetics.
[18] G. G. Galli,et al. PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma , 2019, Nature Communications.
[19] R. Månsson,et al. Bhlhe40 and Bhlhe41 transcription factors regulate alveolar macrophage self‐renewal and identity , 2019, The EMBO journal.
[20] Aviad Tsherniak,et al. Extracting Biological Insights from the Project Achilles Genome-Scale CRISPR Screens in Cancer Cell Lines , 2019, bioRxiv.
[21] T. Graeber,et al. Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies. , 2019, Cancer cell.
[22] Anshul Kundaje,et al. The ENCODE Blacklist: Identification of Problematic Regions of the Genome , 2019, Scientific Reports.
[23] Masato Hoshi,et al. A single-nucleus RNA-sequencing pipeline to decipher the molecular anatomy and pathophysiology of human kidneys , 2019, Nature Communications.
[24] P. Schofield,et al. Hypoxia induces rapid changes to histone methylation and reprograms chromatin , 2019, Science.
[25] Jesse R. Dixon,et al. A non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells , 2018, Nature Communications.
[26] J. Ranish,et al. Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes , 2018, Cell.
[27] C. Lareau,et al. A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation , 2018, Nature Cell Biology.
[28] S. Vanharanta,et al. Endogenous HIF2A reporter systems for high-throughput functional screening , 2018, Scientific Reports.
[29] B. Comin-Anduix,et al. Immunotherapy Resistance by Inflammation-Induced Dedifferentiation. , 2018, Cancer discovery.
[30] S. Vanharanta,et al. NF-κB-Dependent Lymphoid Enhancer Co-option Promotes Renal Carcinoma Metastasis. , 2018, Cancer discovery.
[31] T. Graeber,et al. Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress. , 2018, Cancer cell.
[32] Zoltan Szallasi,et al. Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal , 2018, Cell.
[33] C. Roberts,et al. SWI/SNF (BAF) Complexes: Guardians of the Epigenome , 2018 .
[34] R. Young,et al. Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma. , 2018, Cancer discovery.
[35] Wai Lim Ku,et al. SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters , 2017, Nature Genetics.
[36] Antoine de Weck,et al. Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening , 2017, Cell.
[37] Phillip G. Montgomery,et al. Defining a Cancer Dependency Map , 2017, Cell.
[38] Ann E. Sizemore,et al. Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells , 2017, Nature Genetics.
[39] P. Park,et al. The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers , 2017, Nature Communications.
[40] Levi A Garraway,et al. Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de‐differentiated state , 2017, Molecular systems biology.
[41] O. Kretz,et al. Direct reprogramming of fibroblasts into renal tubular epithelial cells by defined transcription factors , 2016, Nature Cell Biology.
[42] Fidel Ramírez,et al. deepTools2: a next generation web server for deep-sequencing data analysis , 2016, Nucleic Acids Res..
[43] Klaus Hansen,et al. An interactive environment for agile analysis and visualization of ChIP-sequencing data , 2016, Nature Structural &Molecular Biology.
[44] Matteo Benelli,et al. Divergent clonal evolution of castration resistant neuroendocrine prostate cancer , 2016, Nature Medicine.
[45] G. Getz,et al. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer , 2015, Nature Communications.
[46] Hongliang Li,et al. Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease. , 2015, Biochimica et biophysica acta.
[47] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[48] Christof Fellmann,et al. An optimized microRNA backbone for effective single-copy RNAi. , 2013, Cell reports.
[49] E. Lander,et al. Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.
[50] Howard Y. Chang,et al. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position , 2013, Nature Methods.
[51] J. Cheville,et al. The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters , 2013, The American journal of surgical pathology.
[52] The Cancer Genome Atlas Research Network. COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA , 2013, Nature.
[53] R. Buettner,et al. SNAI1-Mediated Epithelial-Mesenchymal Transition Confers Chemoresistance and Cellular Plasticity by Regulating Genes Involved in Cell Death and Stem Cell Maintenance , 2013, PloS one.
[54] G. Crabtree,et al. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy , 2013, Nature Genetics.
[55] A. Viale,et al. Epigenetic expansion of VHL-HIF signal output drives multi-organ metastasis in renal cancer , 2012, Nature Medicine.
[56] J. Landsberg,et al. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation , 2012, Nature.
[57] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[58] Wenjun Guo,et al. Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State , 2012, Cell.
[59] Jolanta Grembecka,et al. Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. , 2012, Nature chemical biology.
[60] C. Glass,et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.
[61] P. Hirvikoski,et al. Evaluation of neuroendocrine markers in renal cell carcinoma , 2010, Diagnostic pathology.
[62] W. Tilley,et al. Breast and prostate cancer: more similar than different , 2010, Nature Reviews Cancer.
[63] M. Mansukhani,et al. Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study , 2009, Modern Pathology.
[64] G. Evan,et al. Distinct thresholds govern Myc's biological output in vivo. , 2008, Cancer cell.
[65] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[66] Jane M J Lin,et al. Identification and Characterization of Cell Type–Specific and Ubiquitous Chromatin Regulatory Structures in the Human Genome , 2007, PLoS genetics.
[67] Kentaro Takahashi,et al. Von Hippel-Lindau Disease , 2024 .
[68] M. Busslinger,et al. Nephric lineage specification by Pax2 and Pax8. , 2002, Genes & development.
[69] Olivier Delattre,et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.
[70] Jacob D. Jaffe,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.
[71] Yui Jin,et al. Stra13 and Sharp-1, the non-grouchy regulators of development and disease. , 2014, Current topics in developmental biology.
[72] P. Krammer,et al. IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. , 2002, Immunity.
[73] T. Taniguchi,et al. IRF family of transcription factors as regulators of host defense. , 2001, Annual review of immunology.